Targeting cellular senescence opens up brand new treatment possibilities for elderly surgical recovery.
A ground-breaking preclinical study has revealed a highly effective strategy for combating age-related skin deterioration by deploying senolytic therapies. Researchers discovered that applying the topical compound ABT-263 to clear out old, “senescent” cells before the regenerative cycle begins can dramatically accelerate wound repair and tissue rejuvenation. This cellular breakthrough carries profound implications for elderly patients undergoing surgical recovery or suffering from painful, hard-to-heal chronic wounds.
About the Author
